ArticleInternational journal of general medicine2026
The Impact of Trait Anxiety on Blood Pressure Variability and Target Organ Damage in Hypertensive Patients: A Cross-Sectional Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a leading global cardiovascular risk factor. Blood pressure variability (BPV) and target organ damage (TOD) are strong predictors of adverse cardiovascular outcomes. Trait anxiety is associated with sympathetic nervous system hyperactivity and hypothalamic-pituitary-adrenal axis dysregulation, both of which may elevate BPV and promote TOD. However, evidence linking trait anxiety to 24-hour BPV and subclinical TOD in hypertension remains limited. This study aimed to investigate the independent association of trait anxiety with BPV and TOD in hypertensive patients, and to clarify its clinical significance and novelty relative to existing literature. Objective: This study aimed to investigate the relationship between trait anxiety and both target organ damage (TOD) and blood pressure variability (BPV) in hypertensive patients. Methods: A cross-sectional observational study was conducted including 285 hypertensive patients. Trait anxiety was measured using the State-Trait Anxiety Inventory (STAI). Ambulatory blood pressure monitoring (ABPM) was performed to assess 24-hour BPV. Cardiac-ankle vascular index (CAVI) and left ventricular mass index (LVMI) were measured on the same day as ABPM after 15 minutes of supine rest to evaluate vascular and cardiac TOD. Multivariate regression and partial correlation analyses were used to examine independent associations. Results: Among the 285 hypertensive patients, 142 were classified into the low trait anxiety group and 143 into the high trait anxiety group, with well-balanced baseline characteristics between groups. Compared with the low anxiety group, patients with high trait anxiety exhibited significantly higher 24-hour systolic and diastolic blood pressure variability (BPV), as well as elevated left ventricular mass index (LVMI) and cardio-ankle vascular index (CAVI) (all P<0.05). Further partial correlation and multivariate regression analyses demonstrated that trait anxiety was independently and strongly associated with 24-hour average real variability (ARV) of systolic blood pressure, 24-hour ARV of diastolic blood pressure, LVMI, and CAVI (all P<0.001). These associations remained statistically significant after adjustment for age, gender, BMI, hypertension duration, medication use, and laboratory confounders. Conclusion: Trait anxiety is independently associated with increased 24-hour BPV and early TOD in hypertensive patients. As a modifiable psychological risk factor, trait anxiety may contribute to cardiovascular remodeling beyond mean blood pressure levels. Routine screening and anxiety intervention may help improve BPV control and reduce TOD progression. These findings provide new evidence for integrated psychological and cardiovascular management of hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.